IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza Signs Licensing and Supply Agreements with California Stem Cell

12:15 AM MDT | June 7, 2010 | Deepti Ramesh

Lonza says it has entered into worldwide, exclusive licensing and supply agreements with California Stem Cell (Irvine, CA), a privately held company that manufactures high-purity human cells for drug discovery, predictive toxicology and clinical application. The Lonza-California Stem Cell collaboration will make novel pluripotent stem cell products readily available to researchers worldwide. “This partnership will address the evolving needs of the research community by making broadly available high purity, human pluripotent stem cell-derived cells and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa